SCHEDULE: HealthCor Funds Disclose 7.9% Stake in Heartflow
Beneficial Ownership Report (Schedule 13G)
HealthCor Partners Management LP and affiliated funds have reported a 7.9% beneficial ownership stake in Heartflow, Inc., totaling 6,697,556 common shares.
Summary
- HealthCor Partners Management LP, along with HealthCor Partners Fund LP, HCPCIV 1, LLC, and HealthCor Partners Fund II, L.P., collectively reported beneficial ownership of 6,697,556 shares of Heartflow, Inc. common stock.
- This aggregate amount represents 7.9% of Heartflow, Inc.'s outstanding common stock.
- The reporting persons share both voting and dispositive power over all 6,697,556 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer, except for activities solely related to a nomination under Rule 240.14a-11.
Sentiment
Score: 5
Explanation: A Schedule 13G filing is a factual disclosure of ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or prospects. The intent stated is passive.
Risks
- The reporting persons certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of Heartflow, Inc., mitigating potential risks of activist investor intervention, other than activities solely in connection with a nomination under Rule 240.14a-11.
Future Outlook
NA
Management Comments
- The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.
Industry Context
NA
Stakeholder Impact
- Shareholders: Disclosure of a significant institutional investor holding a 7.9% stake may influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 08/11/2025 | Date of event which requires filing of this statement. |
| 11/24/2025 | Date of filing of this statement. |
Keywords
Heartflow, HealthCor Partners, Schedule 13G, beneficial ownership, common stock, institutional investor, healthcare technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.